b

biosurfit

59 employees

Biosurfit develops breakthrough technologies that enable fast, precise and affordable blood analysis at the point of care.

Basic info

Industry

medical equipment manufacturing

Sectors

HbA1c
clinical chemistry
C-reactive protein
Surface Plasmon Ressonance (SPR)
Health Care
Point-of-Care
Diagnostics
Technology
PoC testing
bloodcount
IVD
in vitro diagnostic
Diabetes
Medical Device
Medical Devices
hematology
medical diagnostics
Medical
microfluidics
biotech

Date founded

2006

Funding rounds raised

Total raised

$11M

from 4 investors over 4 rounds

b

biosurfit raised $11M on December 14, 2018

Investors: PMEInvestimentos and Boule Diagnostics AB

b

biosurfit raised undisclosed on January 1, 2010

Investors: Caixa Capital, SCR, S.A.

b

biosurfit raised undisclosed on January 1, 2006

Investors: Portugal Ventures

FAQ